Loading...
Demant A/S
WILLF•PNK
Healthcare
Medical - Devices
$43.78
$1.61(3.82%)
Demant A/S (WILLF) Financial Performance & Income Statement Overview
Review Demant A/S’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.11%
↓ 0.11%
Operating Income Growth
6.17%
↑ 6.17%
Net Income Growth
32.98%
↑ 32.98%
Operating Cash Flow Growth
-4.45%
↓ 4.45%
Operating Margin
18.94%
↑ 18.94%
Gross Margin
75.51%
↑ 75.51%
Net Profit Margin
10.76%
↑ 10.76%
ROE
25.40%
↑ 25.40%
ROIC
16.12%
↑ 16.12%
Demant A/S (WILLF) Income Statement & Financial Overview
Review Demant A/S's (WILLF) income statement with detailed quarterly and annual figures.
| Metric | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $11.09B | $11.35B | $5.64B | $11.20B |
| Cost of Revenue | $2.58B | $2.92B | $1.46B | $2.98B |
| Gross Profit | $8.51B | $8.43B | $4.19B | $8.22B |
| Gross Profit Ratio | $0.77 | $0.74 | $0.74 | $0.73 |
| R&D Expenses | $733.00M | $704.00M | $352.00M | $706.00M |
| SG&A Expenses | $5.74B | $5.67B | $2.77B | $5.34B |
| Operating Expenses | $6.32B | $6.37B | $3.26B | $6.04B |
| Total Costs & Expenses | $8.89B | $9.29B | $4.72B | $9.03B |
| Interest Income | $106.00M | $54.00M | $55.00M | $47.00M |
| Interest Expense | $926.00M | $449.00M | $0.00 | $406.00M |
| Depreciation & Amortization | $313.50M | $156.75M | $138.00M | $138.00M |
| EBITDA | $2.36B | $1.22B | $1.20B | $1.20B |
| EBITDA Ratio | $0.21 | $0.11 | $0.21 | $0.10 |
| Operating Income | $2.19B | $2.06B | $1.06B | $2.17B |
| Operating Income Ratio | $0.20 | $0.18 | $0.19 | $0.19 |
| Other Income/Expenses (Net) | -$410.00M | -$197.50M | -$189.00M | -$181.00M |
| Income Before Tax | $1.78B | $1.71B | $869.50M | $1.61B |
| Income Before Tax Ratio | $0.16 | $0.15 | $0.15 | $0.14 |
| Income Tax Expense | $428.00M | $442.00M | $221.00M | $397.00M |
| Net Income | $1.20B | $1.21B | $647.50M | $581.00M |
| Net Income Ratio | $0.11 | $0.11 | $0.11 | $0.05 |
| EPS | $6.18 | $5.44 | $2.90 | $2.60 |
| Diluted EPS | $6.18 | $5.44 | $2.90 | $2.60 |
| Weighted Avg Shares Outstanding | $218.97M | $223.13M | $223.09M | $223.17M |
| Weighted Avg Shares Outstanding (Diluted) | $218.97M | $223.13M | $223.09M | $223.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan